184 related articles for article (PubMed ID: 7159481)
21. Plasma amine oxidase activities in Norrie disease patients with an X-chromosomal deletion affecting monoamine oxidase.
Murphy DL; Sims KB; Karoum F; Garrick NA; de la Chapelle A; Sankila EM; Norio R; Breakefield XO
J Neural Transm Gen Sect; 1991; 83(1-2):1-12. PubMed ID: 2018626
[TBL] [Abstract][Full Text] [Related]
22. Localization of rat striatal monoamine oxidase activities towards dopamine, serotonin and kynuramine by gradient centrifugation and nigro-striatal lesions.
Van der Krogt JA; Koot-Gronsveld E; Van den Berg CJ
Life Sci; 1983 Aug; 33(7):615-23. PubMed ID: 6877035
[TBL] [Abstract][Full Text] [Related]
23. Characteristics of monoamine oxidases in brain and other organs of the golden hamster.
Edwards DJ; Malsbury CW
Biochem Pharmacol; 1978 Mar; 27(6):959-63. PubMed ID: 656143
[No Abstract] [Full Text] [Related]
24. Effect of the monoamine oxidase inhibitors clorgyline and pargyline on the hyperphagia of obese mice.
Feldman JM
Behav Brain Res; 1988 Jul; 29(1-2):147-58. PubMed ID: 2840925
[TBL] [Abstract][Full Text] [Related]
25. Localization of MAO-A and MAO-B in human brain: a step in understanding the therapeutic action of L-deprenyl.
Riederer P; Konradi C; Schay V; Kienzl E; Birkmayer G; Danielczyk W; Sofic E; Youdim MB
Adv Neurol; 1987; 45():111-8. PubMed ID: 3030067
[TBL] [Abstract][Full Text] [Related]
26. [Selective inhibition of type A monoamine oxidase by pyrazidol].
Mashkovskiĭ MD; Gorkin VZ; Verevkina IV; Asnina VV; Tupikina SM
Biull Eksp Biol Med; 1981 Feb; 91(2):169-71. PubMed ID: 7225552
[TBL] [Abstract][Full Text] [Related]
27. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O
J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694
[TBL] [Abstract][Full Text] [Related]
28. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
Severina IS
Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
[TBL] [Abstract][Full Text] [Related]
29. Species differences in monoamine oxidase-A and -B as revealed by sensitivity to trypsin.
White HL; Stine DK
Life Sci; 1984 Aug; 35(8):827-33. PubMed ID: 6482677
[TBL] [Abstract][Full Text] [Related]
30. N-[2-(o-iodophenoxy)ethyl]cyclopropylamine hydrochloride (LY121768), a potent and selective irreversible inhibitor of type A monoamine oxidase.
Fuller RW; Hemrick-Luecke SK; Molloy BB
Biochem Pharmacol; 1983 Apr; 32(7):1243-9. PubMed ID: 6847714
[TBL] [Abstract][Full Text] [Related]
31. Procaine hydrochloride as a monoamine oxidase inhibitor: implications for Geriatric therapy.
Fuller RW; Roush BW
J Am Geriatr Soc; 1977 Feb; 25(2):90-3. PubMed ID: 833415
[TBL] [Abstract][Full Text] [Related]
32. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity].
Severina IS; Klimova GI; Nersisian AA
Biokhimiia; 1981 Nov; 46(11):2043-55. PubMed ID: 6797482
[TBL] [Abstract][Full Text] [Related]
33. [Comparative characteristics of membrane bound and cytoplasmic monoamine oxidases in human placenta].
Kirkel' AZ; Tishchenko LA; Aksenova LN; Pekkel' VA; Gorkin VZ
Vopr Med Khim; 1991; 37(4):25-8. PubMed ID: 1750204
[TBL] [Abstract][Full Text] [Related]
34. Problems with the measurement of monoamine oxidase A protein concentration in mitochondrial preparations. Revised molecular activities and implications for estimating ratios of MAO A:MAO B molecules from radiochemical assay data.
Riley LA; Denney RM
Biochem Pharmacol; 1991 Oct; 42(10):1953-9. PubMed ID: 1741773
[TBL] [Abstract][Full Text] [Related]
35. Ontogeny of multiple forms of monoamine oxidase in mouse brain.
Chordikian FJ; Tabakoff B; Alivisatos SG
Brain Res; 1975 Aug; 93(2):301-8. PubMed ID: 809102
[TBL] [Abstract][Full Text] [Related]
36. Human brain monoamine oxidase: one molecular entity-multiple binding sites?
Schurr A; Ho BT; Schoolar JC
J Pharm Pharmacol; 1981 Mar; 33(3):165-70. PubMed ID: 6116758
[TBL] [Abstract][Full Text] [Related]
37. Monoamine oxidase, phenylethylamine, norepinephrine and schizophrenia.
Wyatt RJ; Karoum F; Stoff DM; Kleinman JE; Gillin JC; Jeste DV; Potkin SG
Clin Genet; 1981 May; 19(5):437-42. PubMed ID: 7296934
[No Abstract] [Full Text] [Related]
38. Studies of selective and reversible monoamine oxidase inhibitors.
Mann JJ; Aarons SF; Frances AJ; Brown RD
J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):62-6. PubMed ID: 6429130
[TBL] [Abstract][Full Text] [Related]
39. Multiplicity of monoamine oxidase in chick brain.
Suzuki O; Oya M; Katsumata Y; Asano M
Experientia; 1979 Feb; 35(2):167-8. PubMed ID: 421820
[TBL] [Abstract][Full Text] [Related]
40. Relation between brain monoamine oxidase (MAO) activity and the firing rate of locus coeruleus neurons.
Oreland L; Engberg G
Naunyn Schmiedebergs Arch Pharmacol; 1986 Jul; 333(3):235-9. PubMed ID: 3762738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
